All Practice Exams

Free Practice Questions for MCPS Family Medicine

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More CPSP Pakistan Postgraduate Medical Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Sample MCPS Family Medicine Practice Questions

Try these sample questions to review concepts for the MCPS Family Medicine exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 52-year-old man has confirmed persistent hypertension, with clinic readings averaging 154/96 mmHg and concordant home measurements. He has no cardiovascular disease, renal impairment, hyperkalemia, or relevant drug contraindication. Using the 2025 AHA/ACC hypertension guideline as the study framework, what is the preferred initial pharmacological strategy alongside lifestyle measures?
A.Initiate dual combination therapy with an ACE inhibitor (or ARB) plus a dihydropyridine calcium channel blocker (or thiazide-like diuretic)
B.Initiate monotherapy with a beta-blocker (e.g., atenolol 50 mg daily)
C.Advise dietary modification and lifestyle interventions alone for 12 months before considering pharmacotherapy
D.Initiate immediate triple therapy with an ACE inhibitor, calcium channel blocker, and loop diuretic
Explanation: In Stage 2 hypertension (blood pressure ≥ 140/90 mmHg or ≥ 20/10 mmHg above goal), guidelines recommend prompt initiation of two first-line antihypertensive agents of different classes—ideally as a single-pill fixed-dose combination (e.g., ACE inhibitor or ARB combined with a calcium channel blocker or thiazide-like diuretic). This achieves faster blood pressure control, improves adherence, and minimizes dose-dependent side effects.
2A 58-year-old male with long-standing hypertension attends the family medicine clinic. His blood pressure remains 156/94 mmHg despite confirmed adherence to full target doses of telmisartan (80 mg), amlodipine (10 mg), and indapamide (2.5 mg) for 3 months. Secondary causes have been excluded, and home blood pressure monitoring confirms sustained hypertension. Serum potassium is 4.3 mEq/L and eGFR is 68 mL/min/1.73 m². What is the recommended next medication to add for resistant hypertension?
A.Low-dose spironolactone (25 mg daily)
B.Oral clonidine 0.1 mg three times daily
C.Oral hydralazine 25 mg twice daily
D.High-dose furosemide 80 mg daily
Explanation: Resistant hypertension is defined as blood pressure that remains above goal despite concurrent use of three antihypertensive agents of different classes (one of which is a diuretic) at optimal doses. According to the PATHWAY-2 trial and major clinical guidelines, low-dose spironolactone (25–50 mg daily) is the most effective fourth-line agent, targeting aldosterone-mediated sodium retention.
3A 46-year-old asymptomatic man has newly confirmed type 2 diabetes, fasting glucose 138 mg/dL, HbA1c 7.2%, and normal renal function. He has no ASCVD, heart failure, CKD, or compelling weight-management indication. After discussing preferences and cost, which oral agent is a reasonable initial treatment alongside lifestyle measures?
A.Metformin
B.Glimepiride
C.Insulin glargine
D.Acarbose
Explanation: Metformin remains the foundational first-line oral pharmacological agent for newly diagnosed type 2 diabetes mellitus due to its proven efficacy in lowering HbA1c, weight neutrality, low risk of hypoglycemia, long-term safety profile, and modest cardiovascular benefits. It should be initiated at a low dose (e.g., 500 mg daily with meals) and titrated upward to minimize gastrointestinal side effects.
4A 60-year-old woman with type 2 diabetes and established hypertension has persistent uACR values of 180–195 mg/g over four months, eGFR 78 mL/min/1.73 m², and BP 146/92 mmHg. Potassium is normal and there is no relevant contraindication. Which antihypertensive class is preferred to treat BP and reduce albuminuric kidney risk?
A.Angiotensin-converting enzyme (ACE) inhibitor or Angiotensin receptor blocker (ARB)
B.Loop diuretic (e.g., furosemide)
C.Non-dihydropyridine calcium channel blocker (e.g., diltiazem)
D.Alpha-1 adrenergic blocker (e.g., doxazosin)
Explanation: The ADA 2026 Standards recommend an ACE inhibitor or ARB for nonpregnant people with diabetes, hypertension, and moderately increased albuminuria. Titrate as tolerated and monitor creatinine and potassium. This recommendation should not be generalized to every normotensive patient with albuminuria; comprehensive kidney protection may also include an SGLT2 inhibitor when appropriate.
5In a teaching case applying the 2026 ACC/AHA dyslipidemia guideline, a 64-year-old man without known ASCVD has LDL-C 142 mg/dL and a 10-year PREVENT-ASCVD risk of 24%. After clinician-patient discussion, lipid-lowering treatment is agreed. Which initial medication strategy is appropriate?
A.High-intensity statin therapy (e.g., atorvastatin 40–80 mg or rosuvastatin 20–40 mg daily)
B.Dietary counseling alone without medication for 12 months
C.Fibrate monotherapy (e.g., fenofibrate 145 mg daily)
D.Over-the-counter omega-3 fatty acid supplements alone
Explanation: The 2026 ACC/AHA guideline uses PREVENT-ASCVD for primary prevention risk assessment and categorizes a 10-year risk of at least 10% as high. High-intensity statin treatment is appropriate to substantially lower LDL-C, with follow-up to assess response and the need for additional therapy. PREVENT and WHO risk charts are different tools; this US guideline example is not a claim that either calculator is interchangeable or locally validated for every Pakistani patient.
6A 56-year-old male with stable exertional angina pectoris takes aspirin 75 mg daily and atorvastatin 40 mg daily. He experiences substernal chest tightness on climbing more than one flight of stairs, which resolves within 3 minutes of resting. His resting heart rate is 84 beats/min and blood pressure is 134/82 mmHg. What is the first-line anti-anginal medication class to reduce myocardial oxygen demand and control exertional symptoms?
A.Cardioselective beta-blocker (e.g., bisoprolol or metoprolol tartrate/succinate)
B.Long-acting oral isosorbide mononitrate monotherapy
C.Immediate coronary artery bypass graft surgery
D.Oral ranolazine monotherapy
Explanation: A beta-blocker is an appropriate initial anti-anginal option here, reducing heart rate and myocardial oxygen demand. A calcium channel blocker is another guideline-supported first-line option, chosen according to comorbidity and tolerance. Symptom relief should not be confused with a universal survival benefit from long-term beta-blockers in every stable coronary patient.
7A 62-year-old male heavy smoker has progressive exertional breathlessness and chronic productive cough. Good-quality post-bronchodilator spirometry on two separate occasions confirms FEV₁/FVC 0.62 and FEV₁ 65% predicted. Clinical assessment supports COPD rather than another cause of persistent obstruction. What is the GOLD spirometric grade?
A.Confirms Chronic Obstructive Pulmonary Disease (COPD); GOLD Grade 2 (moderate airflow limitation)
B.Normal pulmonary function test
C.Reversible bronchial asthma with normal post-bronchodilator spirometry
D.Severe restrictive lung disease
Explanation: In the appropriate clinical context, persistent post-bronchodilator FEV₁/FVC below 0.70 supports COPD. GOLD advises repeat testing on another occasion for a single ratio between 0.60 and 0.80; this stem supplies that confirmation. FEV₁ 65% predicted is GOLD grade 2, the 50–79% range. Spirometric grade is separate from the symptom and exacerbation assessment used to choose treatment.
8A 28-year-old woman has confirmed asthma with symptoms one or two days per week, normal lung function between episodes, and no recent exacerbation. Using GINA 2026 Track 1 Steps 1–2, what is the preferred initial inhaled regimen?
A.As-needed low-dose ICS-formoterol without scheduled maintenance doses at these steps
B.Short-acting beta-2 agonist (SABA, e.g., salbutamol) used alone as needed without an inhaled corticosteroid
C.Oral theophylline 300 mg twice daily monotherapy
D.Oral prednisone 20 mg daily continuous maintenance therapy
Explanation: GINA Track 1 Steps 1–2 use low-dose ICS-formoterol as needed without regular maintenance doses. Maintenance-and-reliever therapy is a different regimen used at higher steps when indicated. ICS-containing treatment reduces exacerbation risk, and SABA-only treatment is not recommended.
9A 48-year-old male presents with recurrent retrosternal burning discomfort and acid regurgitation occurring after heavy meals and when lying flat. He has had symptoms for 6 months. He has no dysphagia, odynophagia, unintentional weight loss, anemia, hematemesis, or family history of upper gastrointestinal malignancy (no red-flag alarm features). What is the appropriate initial primary care management approach for uncomplicated Gastroesophageal Reflux Disease (GERD)?
A.An 8-week empiric trial of once-daily oral Proton Pump Inhibitor (PPI) taken 30–60 minutes before breakfast, along with lifestyle modifications
B.Immediate urgent referral for diagnostic upper gastrointestinal endoscopy
C.Immediate referral for laparoscopic Nissen fundoplication surgery
D.Barium swallow and 24-hour ambulatory esophageal pH monitoring prior to any medication
Explanation: In young to middle-aged patients presenting with typical symptoms of GERD (heartburn and acid regurgitation) in the complete absence of alarm 'red-flag' symptoms (dysphagia, weight loss, vomiting, bleeding, anemia), international guidelines recommend an initial empiric trial of an 8-week once-daily oral PPI, accompanied by lifestyle changes (elevating head of bed, avoiding late meals, weight loss). Endoscopy is reserved for patients with alarm features or those failing empiric PPI therapy.
10A 32-year-old female has nine months of crampy abdominal pain related to defecation, occurring at least twice weekly during the last three months. Pain accompanies changes in stool form and frequency, with loose stools alternating with constipation. She has no bleeding, nocturnal diarrhea, fever, or weight loss. Blood count, inflammatory markers, and celiac serology on a gluten-containing diet are normal. Which diagnosis best fits Rome IV criteria?
A.Irritable bowel syndrome (IBS)
B.Crohn disease
C.Celiac disease
D.Microscopic colitis
Explanation: Rome IV criteria define Irritable Bowel Syndrome (IBS) as recurrent abdominal pain on average at least 1 day per week in the last 3 months, associated with two or more of: (1) Related to defecation; (2) Associated with a change in stool frequency; (3) Associated with a change in stool form/appearance. The absence of alarm features (bleeding, weight loss, nocturnal symptoms) and normal laboratory markers support a confident clinical diagnosis.

About the MCPS Family Medicine Exam

CPSP MCPS in Family Medicine is a postgraduate membership qualification assessed through specialty-specific theory and clinical examinations. This independent English-language bank covers selected primary care topics, with editorial topic allocations rather than a claim to reproduce a complete current syllabus. It is an MCQ study adaptation, not an official translation or format simulation, and cannot substitute for patient-based, oral, examination, procedural, counseling, or TOACS practice. The permitted official assessment language or languages were not confirmed in the public sources checked. Questions naming international guidelines use those study frameworks and do not imply Pakistan national policy.

Exam sponsor: College of Physicians and Surgeons Pakistan (CPSP). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

Two written papers of 100 MCQs each, followed by Task-Oriented Assessment of Clinical Skills (TOACS) with incorporated patients.

Time Limit

Theory timing is provided on the admit card. The published Family Medicine clinical guideline describes 12–20 TOACS stations of 4–8 minutes each; confirm the current station schedule separately.

Passing Score

The current notice does not confirm a numerical theory pass percentage. The published Family Medicine clinical guideline requires 60% aggregate across all TOACS stations, without a minimum number of individually passed stations. Do not apply that clinical threshold to theory.

Exam / Certification Fees

Rs. 15,050 standard Pakistan fee (Rs. 15,000 examination fee plus Rs. 50 handling fee), as confirmed in official 2026 MCPS notifications.

Exam sponsor website

Reported exam pass rate: Not publicly published in official CPSP sources. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

14/100 practice questions

Chronic Disease Management

Hypertension, type 2 diabetes, dyslipidemia, asthma/COPD, chronic kidney disease, and gout.

12/100 practice questions

Common Outpatient Infections

URTI, acute otitis media, UTI, gastroenteritis, typhoid, malaria, dengue, and cutaneous infections.

10/100 practice questions

Maternal and Women's Health

Antenatal care, gestational diabetes, preeclampsia, family planning, AUB, and cervical cancer screening.

12/100 practice questions

Child and Adolescent Health

EPI vaccination schedule, infant feeding, dehydration assessment, acute respiratory infections, and febrile seizures.

10/100 practice questions

Mental Health in Primary Care

Depression, generalized anxiety, panic disorder, somatization, insomnia, and suicide risk assessment.

8/100 practice questions

Primary Care Dermatology

Acne vulgaris, eczema, psoriasis, urticaria, impetigo, scabies, and skin cancer identification.

8/100 practice questions

Musculoskeletal and Minor Procedures

Low back pain red flags, osteoarthritis, shoulder pain, wound repair, abscess drainage, and tetanus prophylaxis.

10/100 practice questions

Preventive Medicine and Screening

Cardiovascular risk calculation, cancer screening guidelines, adult immunizations, and lifestyle counseling.

8/100 practice questions

Geriatric and Palliative Care

Comprehensive geriatric assessment, polypharmacy/Beers criteria, dementia, delirium, and pain management.

8/100 practice questions

Ethics, Communication, and Consultation

Patient-centered communication, ICE model, breaking bad news (SPIKES), informed consent, and confidentiality.

Preparing for the MCPS Family Medicine Exam

What You Need to Know

  • Passing score: The current notice does not confirm a numerical theory pass percentage. The published Family Medicine clinical guideline requires 60% aggregate across all TOACS stations, without a minimum number of individually passed stations. Do not apply that clinical threshold to theory.
  • Assessment: Two written papers of 100 MCQs each, followed by Task-Oriented Assessment of Clinical Skills (TOACS) with incorporated patients.
  • Time limit: Theory timing is provided on the admit card. The published Family Medicine clinical guideline describes 12–20 TOACS stations of 4–8 minutes each; confirm the current station schedule separately.
  • Exam / certification fees: Rs. 15,050 standard Pakistan fee (Rs. 15,000 examination fee plus Rs. 50 handling fee), as confirmed in official 2026 MCPS notifications. Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

MCPS Family Medicine: Suggested Study Strategy

1Master the Integrated Management of Neonatal and Childhood Illness (IMNCI) guidelines and the national EPI vaccination schedule.
2Understand outpatient antimicrobial stewardship, especially distinguishing self-limiting viral illnesses from bacterial infections.
3Focus on comprehensive chronic disease care, including routine screening for microvascular and macrovascular complications of diabetes and hypertension.
4Practice using patient-centered consultation frameworks (such as Calgary-Cambridge and the ICE model) alongside clinical knowledge.
5Review common dermatological presentations in primary care and understand safe, age-appropriate topical corticosteroid usage.

Frequently Asked Questions

What is the CPSP MCPS in Family Medicine?

MCPS (Member of the College of Physicians and Surgeons Pakistan) in Family Medicine is a diploma-level membership qualification recognizing proficiency in primary care and general practice.

What are the eligibility pathways for MCPS Family Medicine?

CPSP describes two-year structured membership training and a separate experienced-practitioner route. Its 2022 Family Medicine notice allows practitioner registration after three years to complete workshops, with examination eligibility after five years of standing. Confirm which route remains applicable to you and its current registration, workshop, training, and documentation requirements directly with CPSP.

What is the examination format for Family Medicine?

The examination comprises two written theory papers of 100 MCQs each (200 total), followed by a clinical TOACS examination featuring incorporated patients across primary care stations.

What is the examination fee in Pakistan?

Official 2026 CPSP notifications confirm a standard Pakistan fee of Rs. 15,050 (Rs. 15,000 examination fee plus Rs. 50 handling fee).

Are these MCQs a substitute for clinical TOACS training?

No. These independent practice questions serve as a study tool for core theoretical concepts in family practice. They are not an official CPSP simulation and do not replace hands-on patient care or clinical skills training.

Is MCPS an association membership like CFMP?

No. MCPS is a formal postgraduate membership examination and qualification awarded by the statutory body CPSP upon passing written and clinical assessments.